Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data.

PURPOSE To study the effects of increasing pelvic bone marrow (BM) radiation dose on acute hematologic toxicity in patients undergoing chemoradiotherapy, using a novel modeling approach to preserve the local spatial dose information. METHODS AND MATERIALS The study included 37 cervical cancer patients treated with concurrent weekly cisplatin and pelvic radiation therapy. The white blood cell count nadir during treatment was used as the indicator for acute hematologic toxicity. Pelvic BM radiation dose distributions were standardized across patients by registering the pelvic BM volumes to a common template, followed by dose remapping using deformable image registration, resulting in a dose array. Principal component (PC) analysis was applied to the dose array, and the significant eigenvectors were identified by linear regression on the PCs. The coefficients for PC regression and significant eigenvectors were represented in three dimensions to identify critical BM subregions where dose accumulation is associated with hematologic toxicity. RESULTS We identified five PCs associated with acute hematologic toxicity. PC analysis regression modeling explained a high proportion of the variation in acute hematologicity (adjusted R(2), 0.49). Three-dimensional rendering of a linear combination of the significant eigenvectors revealed patterns consistent with anatomical distributions of hematopoietically active BM. CONCLUSIONS We have developed a novel approach that preserves spatial dose information to model effects of radiation dose on toxicity, which may be useful in optimizing radiation techniques to avoid critical subregions of normal tissues. Further validation of this approach in a large cohort is ongoing.

[1]  A. Mohar,et al.  Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study. , 2005, International journal of radiation oncology, biology, physics.

[2]  John C Roeske,et al.  Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. , 2009, International journal of radiation oncology, biology, physics.

[3]  John C Roeske,et al.  Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[4]  G. Lockwood,et al.  Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer. , 2007, International journal of radiation oncology, biology, physics.

[5]  John C. Roeske,et al.  Incorporation of magnetic resonance imaging into intensity modulated whole-pelvic radiation therapy treatment planning to reduce the volume of pelvic bone marrow irradiated , 2004, CARS.

[6]  W A Murphy,et al.  Bone marrow imaging. , 1988, Radiology.

[7]  P. Xia,et al.  Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. , 2000, International journal of radiation oncology, biology, physics.

[8]  Charles R. Thomas,et al.  Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. , 2008, JAMA.

[9]  B N Bundy,et al.  Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Deshan Yang,et al.  A fast inverse consistent deformable image registration method based on symmetric optical flow computation , 2008, 2008 42nd Asilomar Conference on Signals, Systems and Computers.

[11]  J. Tierney,et al.  Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. , 2005, The Cochrane database of systematic reviews.

[12]  Stephen H. D. Jackson INT CONGR SER , 2001 .

[13]  D. Louis,et al.  Bone marrow imaging. , 1989, Radiology.

[14]  F. A. Gerber,et al.  Proposed procedure for identification of dispersive soils by chemical testing : : technical paper , 1987 .

[15]  J. Roeske,et al.  Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Kevin S. Richards,et al.  Critical appraisal of piping phenomena in earth dams , 2007 .

[17]  R. E. Ellis,et al.  The distribution of active bone marrow in the adult. , 1961, Physics in medicine and biology.

[18]  Ian T. Jolliffe,et al.  Principal Component Analysis , 2002, International Encyclopedia of Statistical Science.

[19]  John C Roeske,et al.  Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[20]  P. Grigsby,et al.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  J Sullivan,et al.  Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. , 1995, International journal of radiation oncology, biology, physics.

[22]  N. Petrelli,et al.  Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  H. Bartelink,et al.  Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  John C Roeske,et al.  Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. , 2008, International journal of radiation oncology, biology, physics.

[25]  B N Bundy,et al.  Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. , 1999, The New England journal of medicine.

[26]  E. Rofstad,et al.  Female pelvic bone marrow: serial MR imaging before, during, and after radiation therapy. , 1995, Radiology.

[27]  John C Roeske,et al.  Incorporation of SPECT bone marrow imaging into intensity modulated whole-pelvic radiation therapy treatment planning for gynecologic malignancies. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  C. Ling,et al.  10 – Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy , 2010 .

[29]  A. Alavi,et al.  Magnetic Resonance Imaging Based Bone Marrow Segmentation for Quantitative Calculation of Pure Red Marrow Metabolism Using 2-Deoxy-2-[F-18]fluoro-d-glucose- Positron Emission Tomography: a Novel Application with Significant Implications for Combined Structure–Function Approach , 2007, Molecular Imaging and Biology.

[30]  John C Roeske,et al.  A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  S Landman,et al.  Bone marrow regeneration and extension after extended field irradiation in Hodgkin's disease , 1973, Cancer.

[32]  R Mohan,et al.  Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. , 1996, International journal of radiation oncology, biology, physics.

[33]  Patricia J Eifel,et al.  Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. , 2008, International journal of radiation oncology, biology, physics.

[34]  G. Lockwood,et al.  Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiation. , 2005, International journal of radiation oncology, biology, physics.

[35]  J. Roeske,et al.  Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[36]  K. Mehta,et al.  Dose Constraint Recommendations and a Predictive Nomogram of Incidence of Hematological Toxicity for Cervix Cancer Patients Treated with Concurrent Cisplatin and Intensity Modulated Radiation Therapy (IMRT) , 2008 .

[37]  C. Ling,et al.  Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. , 1997, International journal of radiation oncology, biology, physics.

[38]  R. James Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin , 1996, The Lancet.

[39]  Di Yan,et al.  Principal component analysis-based pattern analysis of dose-volume histograms and influence on rectal toxicity. , 2007, International journal of radiation oncology, biology, physics.

[40]  Robert C. Frazier,et al.  Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. , 2000, International journal of radiation oncology, biology, physics.

[41]  K. Parker,et al.  Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution. , 2009, International journal of radiation oncology, biology, physics.

[42]  L Souhami,et al.  Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  P J Eifel,et al.  Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. , 1999, The New England journal of medicine.

[44]  B N Bundy,et al.  Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. , 1999, The New England journal of medicine.

[45]  F. G. Bell,et al.  Dispersive soils: a review from a South African perspective , 1994, Quarterly Journal of Engineering Geology.

[46]  Steven A. Leibel,et al.  Textbook of Radiation Oncology , 1998 .

[47]  M. Borgognone,et al.  Principal component analysis in sensory analysis: covariance or correlation matrix? , 2001 .

[48]  G. Gold,et al.  Iterative decomposition of water and fat with echo asymmetry and least‐squares estimation (IDEAL): Application with fast spin‐echo imaging , 2005, Magnetic resonance in medicine.